Jackman W M, Wang X Z, Friday K J, Roman C A, Moulton K P, Beckman K J, McClelland J H, Twidale N, Hazlitt H A, Prior M I
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
N Engl J Med. 1991 Jun 6;324(23):1605-11. doi: 10.1056/NEJM199106063242301.
Surgical or catheter ablation of accessory pathways by means of high-energy shocks serves as definitive therapy for patients with Wolff-Parkinson-White syndrome but has substantial associated morbidity and mortality. Radiofrequency current, an alternative energy source for ablation, produces smaller lesions without adverse effects remote from the site where current is delivered. We conducted this study to develop catheter techniques for delivering radiofrequency current to reduce morbidity and mortality associated with accessory-pathway ablation.
Radiofrequency current (mean power, 30.9 +/- 5.3 W) was applied through a catheter electrode positioned against the mitral or tricuspid annulus or a branch of the coronary sinus; when possible, delivery was guided by catheter recordings of accessory-pathway activation. Ablation was attempted in 166 patients with 177 accessory pathways (106 pathways in the left free wall, 13 in the anteroseptal region, 43 in the posteroseptal region, and 15 in the right free wall).
Accessory-pathway conduction was eliminated in 164 of 166 patients (99 percent) by a median of three applications of radiofrequency current. During a mean follow-up (+/- SD) of 8.0 +/- 5.4 months, preexcitation or atrioventricular reentrant tachycardia returned in 15 patients (9 percent). All underwent a second, successful ablation. Electrophysiologic study 3.1 +/- 1.9 months after ablation in 75 patients verified the absence of accessory-pathway conduction in all. Complications of radiofrequency-current application occurred in three patients (1.8 percent): atrioventricular block (one patient), pericarditis (one), and cardiac tamponade (one) after radiofrequency current was applied in a small branch of the coronary sinus.
Radiofrequency current is highly effective in ablating accessory pathways, with low morbidity and no mortality.
通过高能电击对旁路进行手术或导管消融是预激综合征患者的确定性治疗方法,但具有较高的相关发病率和死亡率。射频电流作为一种替代的消融能源,产生的损伤较小,且在电流输送部位以外无不良影响。我们开展本研究以开发用于输送射频电流的导管技术,以降低与旁路消融相关的发病率和死亡率。
通过置于二尖瓣或三尖瓣环或冠状静脉窦分支处的导管电极施加射频电流(平均功率,30.9±5.3W);尽可能通过旁路激动的导管记录来指导电流输送。对166例患者的177条旁路进行消融尝试(左游离壁106条旁路,前间隔区域13条,后间隔区域43条,右游离壁15条)。
166例患者中的164例(99%)通过中位三次射频电流应用消除了旁路传导。在平均随访(±标准差)8.0±5.4个月期间,15例患者(9%)出现预激或房室折返性心动过速复发。所有患者均接受了第二次成功消融。75例患者在消融后3.1±1.9个月进行的电生理研究证实所有患者均无旁路传导。射频电流应用的并发症发生在3例患者(1.8%)中:在冠状静脉窦一小分支应用射频电流后出现房室传导阻滞(1例患者)、心包炎(1例)和心脏压塞(1例)。
射频电流在消融旁路方面非常有效,发病率低且无死亡病例。